Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

HIV Infections 1Condylomata Acuminata 1Acquired Immunodeficiency Syndrome 1AIDS-Related Opportunistic Infections 1AIDS-Related Complex 1

Interventions

Doxorubicin 5tecogalan 4Liposomes 4Vincristine 3Bleomycin 3Mitoxantrone 2ziconotide 1vesnarinone 1tin etiopurpurin 1human papillomavirus vaccine, L1 type 16, 18 1Zidovudine 1Tumor Necrosis Factor-alpha 1Sugars 1Semaxinib 1Ro 24-7429 1Ritonavir 1Paclitaxel 1Mitoguazone 1Maraviroc 1Maltose 1Interferon-alpha 1Inosine Pranobex 1Etoposide 1Daunorubicin 1Cidofovir 1Bexarotene 14,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 13-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Acquired Immunodeficiency Syndrome × Cidofovir × Clear all
NCT00002327 2005-06-24

The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients

NIH AIDS Clinical Trials Information Service

Phase 1 Completed
40 enrolled

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Condylomata Acuminata, HIV Infections, AIDS-Related Opportunistic Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡